IAMU
GILD icon

Impax Asset Management (UK)’s Gilead Sciences GILD Stock Holding History

Impax Asset Management (UK)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-700
Closed -$82K – 68
2015
Q2 		$82K Buy
+700
New +$76.5K 0.01% 74

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Impax Asset Management (UK)'s GILD Position: Q3 2015 in Review

Impax Asset Management (UK) sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 700 shares — an estimated $82K sold.

Impax Asset Management (UK) first reported a position in GILD in Q2 2015 and held it in 1 quarter. The position peaked at $82K in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

  • Impax Asset Management (UK) reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
  • Impax Asset Management (UK) sold 700 Gilead Sciences shares in Q3 2015, an estimated $82K.
  • Impax Asset Management (UK) first reported a position in Gilead Sciences in Q2 2015 and held it in 1 quarter.
  • Impax Asset Management (UK)'s Gilead Sciences position peaked at $82K in Q2 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Impax Asset Management (UK)'s 13F filing for Q3 2015, filed 12 Nov 2015.